Rachel K. Hoyles

A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

Rachel K. Hoyles, R Ellis, Jessica Wellsbury et al. · Arthritis & Rheumatism · 2006 · 724 citations

Short‐Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis

Nicole Goh, Rachel K. Hoyles, Christopher P. Denton et al. · Arthritis & Rheumatology · 2017 · 342 citations

Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial

Toby M. Maher, Veronica A Tudor, Peter Saunders et al. · The Lancet Respiratory Medicine · 2022 · 245 citations · Full text

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

Thomas M Drake, Annemarie B Docherty, Ewen M. Harrison et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 228 citations · Full text

Pivotal role of connective tissue growth factor in lung fibrosis: MAPK‐dependent transcriptional activation of type I collagen

Markella Ponticos, Alan Holmes, Shiwen Xu et al. · Arthritis & Rheumatism · 2009 · 220 citations